Edition:
United Kingdom

Magellan Health Inc (MGLN.OQ)

MGLN.OQ on NASDAQ Stock Exchange Global Select Market

97.35USD
11 Dec 2017
Change (% chg)

-- (--)
Prev Close
$97.35
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
51,394
52-wk High
$99.20
52-wk Low
$64.05

Chart for

About

Magellan Health, Inc. is engaged in the healthcare management business. The Company's segments include Healthcare, Pharmacy Management and Corporate. It is focused on managing special populations, complete pharmacy benefits and other specialty areas of healthcare. Its Healthcare includes its management of behavioral healthcare... (more)

Overall

Beta: 0.55
Market Cap(Mil.): $2,044.99
Shares Outstanding(Mil.): 23.68
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 23.29 16.44
EPS (TTM): -- -- --
ROI: -- -0.03 10.62
ROE: -- 15.67 14.20

BRIEF-Magellan Health reports qtrly earnings per share $1.32

* Magellan Health reports third quarter 2017 financial results

01 Nov 2017

BRIEF-Magellan Health Inc receives regulatory approvals to acquire Senior Whole Health

* Magellan Health Inc receives regulatory approvals to acquire Senior Whole Health

09 Oct 2017

BRIEF-Magellan Health announces closing of $400 million of 4.40 percent senior notes due 2024

* Magellan Health announces closing of $400 million of 4.40 percent senior notes due 2024 and refinancing of senior credit facility

25 Sep 2017

BRIEF-Magellan Health priced public offering of $400 mln aggregate principal amount of 4.4 pct senior notes due 2024 - SEC Filing

* Magellan Health Inc - On Sept 15, 2017, priced public offering of $400.0 million aggregate principal amount of 4.400% senior notes due 2024 - SEC Filing Source text: [http://bit.ly/2wqSl6U] Further company coverage:

18 Sep 2017

BRIEF-Magellan Health qtrly earnings per share $ 0.23

* Magellan Health reports second quarter 2017 financial results

28 Jul 2017

BRIEF-Magellan Health to acquire Senior Whole Health

* Under terms of agreement, Magellan will acquire SWH, a privately held company, for approximately $400 million

13 Jul 2017

BRIEF-Magellan Health affirms its 2017 guidance

* Company affirms its 2017 guidance Source text for Eikon: Further company coverage:

21 Jun 2017

Earnings vs. Estimates